1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. EXELIXIS INC
Exelixis Inc XNAS: EXEL

Exelixis Inc Live Stock Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and f...

Read More
42.93 1.28 (3.07%)
34.58% Gain from 52W Low
944.3K
XNAS Volume

XNAS 17 Nov, 2025 1:21 PM (EST)

Watchlist

Portfolio

Alert
Durability score
High Financial Strength
72.2 / 100
Valuation Score
Mid Valuation
44.8 / 100
Momentum Score
Technically Moderately Bullish
60.5 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM
Analyst Price Target
45
1Yr Price target upside is 5%
18 analysts

24

S

4

W

2

O

3

T

SWOT Analysis

Exelixis Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..